Show simple item record

dc.contributor.authorReynolds, LAen_US
dc.contributor.authorTansey, EMen_US
dc.contributor.editorREYNOLDS, LAen_US
dc.contributor.editorTANSEY, EMen_US
dc.date.accessioned2012-10-10T15:39:27Z
dc.date.issued2009-12en_US
dc.identifier.isbn0854841237en_US
dc.identifier.isbn9780854841233en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/2779
dc.descriptionAnnotated and edited transcript of a Witness Seminar held on 13 May 2008. Introduction by Professor Anne M Johnson, Division of Population Health and Institute for Global Health, UCL. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2009. ©The Trustee of the Wellcome Trust, London, 2009. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/en_US
dc.descriptionAnnotated and edited transcript of a Witness Seminar held on 13 May 2008. Introduction by Professor Anne M Johnson, Division of Population Health and Institute for Global Health, UCL
dc.descriptionAnnotated and edited transcript of a Witness Seminar held on 13 May 2008. Introduction by Professor Anne M Johnson, Division of Population Health and Institute for Global Health, UCLen_US
dc.descriptionAnnotated and edited transcript of a Witness Seminar held on 13 May 2008. Introduction by Professor Anne M Johnson, Division of Population Health and Institute for Global Health, UCLen_US
dc.descriptionAnnotated and edited transcript of a Witness Seminar held on 13 May 2008. Introduction by Professor Anne M Johnson, Division of Population Health and Institute for Global Health, UCLen_US
dc.description.abstractThe history, largely untold, of the development of cervical cytology, of effective screening and its ultimate success in reducing cervical cancer incidence and mortality, and the viral cause of cervical cancer, took place within a complex social background of changing attitudes to women’s health and sexual behaviour. Dr Georges Papanicolaou’s screening method (the Pap smear) started in the US in the 1940s. It was widely used in the UK a decade later and a national programme of cervical screening was established in 1988. The association of sexually transmitted human papillomavirus (HPV) with cervical cancer was less readily accepted. The detection of HPV16 in cervical cancers at the end of the 1970s was aided by the explosion of laboratory, clinical, and public health research on new screening tests and procedures. These made possible the successful development, licensing and use of preventive vaccines against the major oncogenic HPV types, HPV16 and -18. The Witness Seminar was attended by virologists, cytologists, gynaecologists, epidemiologists and others and addressed the development of cytology as a pathological discipline. They discussed who became cytologists and screeners; the evolution of screening in the UK and elsewhere; the impacts of colposcopy and of HPV; and the discovery of virus-like particles and the development of the HPV vaccine. The meeting was chaired by Professor Glenn McCluggage and the topic was suggested by Professor David Jenkins. Contributors include: Professor Valerie Beral, Professor Saveria Campo, Professor Jocelyn Chamberlain, Professor Dulcie Coleman, Dr Lionel Crawford, Professor Heather Cubie, Professor Jack Cuzick, Dr Ian Duncan, Dr Winifred Gray, Dr Amanda Herbert, Professor David Jenkins, Dr Elizabeth Mackenzie, Dr Joan Macnab, Professor Anthony Miller, Professor Julian Peto, Dr Catherine Pike, Professor Peter Sasieni, Professor Albert Singer, Dr John Smith, Professor Margaret Stanley, Mrs Marilyn Symonds, Dr Anne Szarewski, Professor Leslie Walker, Mr Patrick Walker, Dr Margaret Wolfendale and Professor Ciaran Woodman. Two appendices with reminiscences from Professor Leopold Koss, Dr Arthur Spriggs and Dr O A N (Nasseem) Husain complete the volume. Reynolds L A, Tansey E M. (eds) (2009) History of cervical cancer and the role of human papillomavirus, 1960–2000, Wellcome Witnesses to Twentieth Century Medicine, vol. 38. London: The Wellcome Trust Centre for the History of Medicine at UCL. ISBN 978 085484 1233en_US
dc.description.sponsorshipThe Wellcome Trust Centre for the History of MedicineMat UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183.en_US
dc.format.extenti - 164 (192)en_US
dc.format.mediumpaper and open access
dc.format.mediumpaper and open access
dc.format.mediumpaper and open accessen_US
dc.format.mediumpaper and open accessen_US
dc.format.mediumpaper and open accessen_US
dc.language.isoenen_US
dc.publisherWellcome Trust Centre for the History of Medicine at UCLen_US
dc.relation.ispartofWellcome Witnesses to Twentieth Century Medicineen_US
dc.subjectGeorge Papanicolaouen_US
dc.subjectcervical cytologyen_US
dc.subjectvirus-like particlesen_US
dc.subjectHPV testingen_US
dc.subjectfemale genital canceren_US
dc.subjectnational NHS screening programmeen_US
dc.titleHistory of Cervical Cancer and the Role of the Human Papillomavirus, 1960-2000en_US
dc.typeBook
pubs.notesNot knownen_US
pubs.place-of-publicationLONDONen_US
pubs.publication-statusPublisheden_US
pubs.volume38en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record